Van Eck Associates Corp Bristol Myers Squibb CO Transaction History
Van Eck Associates Corp
- $108 Billion
- Q3 2025
A detailed history of Van Eck Associates Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Eck Associates Corp holds 9,859,915 shares of BMY stock, worth $462 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
9,859,915
Previous 3,926,110
151.14%
Holding current value
$462 Million
Previous $182 Million
144.68%
% of portfolio
0.41%
Previous 0.21%
Shares
34 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...